Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials.

Br J Cancer

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Published: March 2018

The article DOI: 10.1038/bjc.2017.85 has been corrected to address inaccuracies or updates in the original publication.
This correction ensures that future readers have access to the most accurate information.
Readers are encouraged to refer to the corrected version for reliable data and conclusions.

This corrects the article DOI: 10.1038/bjc.2017.85.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886120	PMC
http://dx.doi.org/10.1038/bjc.2017.480	DOI Listing

Publication Analysis

development prognostic

prognostic scoring

scoring system

system patients

patients advanced

advanced cancer

cancer enrolled

enrolled immune

immune checkpoint

checkpoint inhibitor

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!